Vyne Therapeutics Inc (NASDAQ:VYNE)

0.2637
Delayed Data
As of 3:52pm ET
 +0.0047 / +1.81%
Today’s Change
0.11
Today|||52-Week Range
0.79
+75.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Quarter 2
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization4.0K12.0K191.0K166.0K
 
 
 
 
 
 
Operating ExpensesGross Income-4.0K-12.0K-191.0K-166.0K
 
 
 
 
 
General Expenses13.7M18.4M19.5M17.1M
 
 
 
 
 
Research And Development10.7M15.1M15.9M13.5M
 
 
 
 
 
Total Operating Expenses13.7M18.4M19.7M17.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-13.7M-18.4M-19.7M-17.2M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.8M-17.6M-18.9M-16.5M
 
 
 
 
 
Net Income-12.8M-17.6M-18.9M-16.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS23.0M23.2M23.3M23.9M
 
 
 
 
 
Shares To Calculate EPS Diluted23.0M23.2M23.3M23.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.56-$0.76-$0.81-$0.69
 
 
 
 
 
EPS Diluted-$0.56-$0.76-$0.81-$0.69